CAS 2543673-19-2

1,4-Oxazepin-5(2H)-one, 4-[3-[[2-[[2-ethyl-4-(4-methyl-1-piperazinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]propyl]tetrahydro-

Description:

1,4-Oxazepin-5(2H)-one, 4-[3-[[2-[[2-ethyl-4-(4-methyl-1-piperazinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]propyl]tetrahydro- is a complex organic compound characterized by its oxazepin core structure, which features a seven-membered ring containing both nitrogen and oxygen atoms. This compound is likely to exhibit properties typical of heterocyclic compounds, including potential biological activity due to the presence of various functional groups such as amines and trifluoromethyl groups. The presence of a piperazine moiety suggests possible interactions with biological targets, making it of interest in medicinal chemistry. Its molecular structure indicates potential for solubility in organic solvents, while the trifluoromethyl group may enhance lipophilicity and metabolic stability. The compound's CAS number, 2543673-19-2, allows for precise identification in chemical databases, facilitating research and development in pharmaceutical applications. Overall, this substance may possess unique pharmacological properties, warranting further investigation into its efficacy and safety profiles.

Formula: C₂₆H₃₆F₃N₇O₂

Synonyms:

• SGR-1505/DCC3116
• 4-(3-((2-((2-ethyl-4-(4-methylpiperazin-1-yl)phenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)propyl)-1,4-oxazepan-5-one
• 1,4-Oxazepin-5(2H)-one, 4-[3-[[2-[[2-ethyl-4-(4-methyl-1-piperazinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]propyl]tetrahydro-

DCC-3116

CAS: 2543673-19-2

DCC-3116

Purity: ≥98%

Molecular weight: 535.61g/mol

Ref: 54-BUP01756

DCC-3116

CAS: 2543673-19-2

DCC-3116 is an orally active, selective and potent ULK1/2 inhibitor with anticancer activity.DCC-3116 inhibits autophagy and can be used in cancer research.

Formula: C₂₆H₃₆F₃N₇O₂

Purity: 98.55%

Color and Shape: Soild

Molecular weight: 535.61

Ref: TM-T86167